학술논문
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Document Type
Article
Author
Choueiri, T.K.; Motzer, R.J.; Rini, B.I.; Haanen, J.; Campbell, M.T.; Venugopal, B.; Kollmannsberger, C.; Gravis-Mescam, G.; Uemura, M.; Lee, J.L.; Grimm, M.-O.; Gurney, H.; Schmidinger, M.; Larkin, J.; Atkins, M.B.; Pal, S.K.; Wang, J.; Mariani, M.; Krishnaswami, S.; Cislo, P.; Chudnovsky, A.; Fowst, C.; Huang, B.; di Pietro, A.; Albiges, L.
Source
In Annals of Oncology August 2020 31(8):1030-1039
Subject
Language
ISSN
0923-7534